Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Paraneoplastic neuromyopathy and neuropathy |
French
|
Neuromyopathie et neuropathie paranéoplasiques |
| Level | Code | Title | |
|---|---|---|---|
| 1 | VI | Diseases of the nervous system | |
| 2 | G10-G14 | Systemic atrophies primarily affecting the central nervous system | |
| 3 | G13 | Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere | |
| 4 | G13.0 | Paraneoplastic neuromyopathy and neuropathy |
| Active Ingredient | Description | |
|---|---|---|
| Ifosfamide |
Ifosfamide is an antineoplastic, a cytotoxic alkylating agent. It is a prodrug and shows no in vitro cytotoxic activity until activated by microsomal enzymes. The cytotoxic activity of ifosfamide (alkylation of the nucleophilic centres in the cells) is associated with the activated oxazaphosphorine ring hydroxylated at the C4 atom which interacts with DNA-DNA cross linking. This activity manifests itself by blocking the late S and early G2 phases of the cell cycle. |
